Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

A novel Mecp2Y120D knock-in model displays similar behavioral traits but distinct molecular features compared to the Mecp2-null mouse implying precision medicine for the treatment of Rett syndrome

Gandaglia, Anna, Brivio, Elena, Carli, Sara, Palmieri, Michela, Bedogni, Francesco, Stefanelli, Gilda, Bergo, Anna, Leva, Barbara, Cattaneo, Chiara, Pizzamiglio, Lara, Cicerone, Marco, Bianchi, Veronica, Kilstrup-Nielsen, Charlotte, D?Annessa, Ilda, Di Marino, Daniele, D?Adamo, Patrizia, Antonucci, Flavia, Frasca, Angelisa and Landsberger, Nicoletta 2019. A novel Mecp2Y120D knock-in model displays similar behavioral traits but distinct molecular features compared to the Mecp2-null mouse implying precision medicine for the treatment of Rett syndrome. Molecular Neurobiology 56 (7) , pp. 4838-4854. 10.1007/s12035-018-1412-2

Full text not available from this repository.

Abstract

MeCP2 is a fundamental protein associated with several neurological disorders, including Rett syndrome. It is considered a multifunctional factor with a prominent role in regulating chromatin structure; however, a full comprehension of the consequences of its deficiency is still lacking. Here, we characterize a novel mouse model of Mecp2 bearing the human mutation Y120D, which is localized in the methyl-binding domain. As most models of Mecp2, the Mecp2Y120D mouse develops a severe Rett-like phenotype. This mutation alters the interaction of the protein with chromatin, but surprisingly, it also impairs its association with corepressors independently on the involved interacting domains. These features, which become overt mainly in the mature brain, cause a more accessible and transcriptionally active chromatin structure; conversely, in the Mecp2-null brain, we find a less accessible and transcriptionally inactive chromatin. By demonstrating that different MECP2 mutations can produce concordant neurological phenotypes but discordant molecular features, we highlight the importance of considering personalized approaches for the treatment of Rett syndrome.

Item Type: Article
Date Type: Publication
Schools: Biosciences
Publisher: Humana Press
ISSN: 0893-7648
Date of Acceptance: 24 October 2018
Last Modified: 16 Jun 2020 11:30
URI: https://orca.cardiff.ac.uk/id/eprint/132450

Citation Data

Cited 18 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item